Latest News

Request for information on Rosuvastatin calcium to be considered by the OEHHA Science Advisory Board's Carcinogen Identification Committee.

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Methyl Parathion. These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in this report.

Background materials for CIC consultation on OEHHA's proposed acrylamide workplan.

OEHHA adopted revised Toxicity Equivalency Factors (TEF WHO-97) for PCDDs, PCDFs, and Dioxin-Like PCBs. 

OEHHA adopted the WHO97 Toxicity Equivalency Factors (TEFWHO-97) for polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs), and for dioxin-like polychlorinated biphenyls (PCBs) which were derived by the World Health Organization.  The Scientific Review Panel reviewed and endorsed the equivalency factors at its June 20, 2003 meeting.

Notice of intent to list chemical; extension of public comment period: fumonisin B1

Notice of Intent to List as known to cause cancer under the authoritative bodies mechanism: Fumonisin B1

The proposed acrylamide work plan outlines four different actions that will provide guidance on the applicability of Proposition 65 to foods.

Draft and final hazard identification documents for the carcinogenicity of chloral hydrate.

Draft Hazard Identification Documents on the Reproductive Toxicity of Propachlor and Phenol